161 related articles for article (PubMed ID: 25400816)
1. Coexistence of homologous-type cervical carcinosarcoma with endometrioid-type G1 endometrial cancer: a case report with an immunohistochemical study.
Semczuk A; Colas E; Walczyna B; Joźwik M; Pyra A; Semczuk-Sikora A; Rechberger T
Int J Clin Exp Pathol; 2014; 7(10):7191-5. PubMed ID: 25400816
[TBL] [Abstract][Full Text] [Related]
2. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
[TBL] [Abstract][Full Text] [Related]
4. Panel of Villin, Pro-Ex-C, Estrogen Receptor and Progesterone Receptor Expressions Could Help in Differentiation Between Endocervical and Endometrioid Adenocarcinoma.
Elfeky M; Harb O; Gertallah L
Turk Patoloji Derg; 2017; 1(1):29-40. PubMed ID: 28832070
[TBL] [Abstract][Full Text] [Related]
5. Distinct molecular landscapes between endometrioid and nonendometrioid uterine carcinomas.
Jones NL; Xiu J; Chatterjee-Paer S; Buckley de Meritens A; Burke WM; Tergas AI; Wright JD; Hou JY
Int J Cancer; 2017 Mar; 140(6):1396-1404. PubMed ID: 27905110
[TBL] [Abstract][Full Text] [Related]
6. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
[TBL] [Abstract][Full Text] [Related]
7. BRG1, INI1, and ARID1B Deficiency in Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of a Large Series From a Single Institution.
Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
Am J Surg Pathol; 2020 Dec; 44(12):1712-1724. PubMed ID: 32910019
[TBL] [Abstract][Full Text] [Related]
8. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
9. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
Liou S; Nilforoushan N; Kang Y; Moatamed NA
Diagn Pathol; 2021 Sep; 16(1):85. PubMed ID: 34544445
[TBL] [Abstract][Full Text] [Related]
10. Polypoid nodular histiocytic hyperplasia associated with endometrioid adenocarcinoma of the endometrium: report of a case.
Akhter S; Lawrence WD; Quddus MR
Diagn Pathol; 2014 May; 9():93. PubMed ID: 24885845
[TBL] [Abstract][Full Text] [Related]
11. Triple synchronous malignancies of the female genital tract with an advanced stage carcinosarcoma of the uterine cervix: A case report.
Hsu LC; Chiang AJ
Taiwan J Obstet Gynecol; 2020 Jul; 59(4):613-614. PubMed ID: 32653141
[No Abstract] [Full Text] [Related]
12. Endometrioid endometrial adenocarcinoma recurring as carcinosarcoma.
Shaco-Levy R; Piura B
J Obstet Gynaecol Res; 2008 Apr; 34(2):279-82. PubMed ID: 18412798
[TBL] [Abstract][Full Text] [Related]
13. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.
Tafe LJ; Garg K; Chew I; Tornos C; Soslow RA
Mod Pathol; 2010 Jun; 23(6):781-9. PubMed ID: 20305618
[TBL] [Abstract][Full Text] [Related]
14. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
15. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas.
Werner HM; Berg A; Wik E; Birkeland E; Krakstad C; Kusonmano K; Petersen K; Kalland KH; Oyan AM; Akslen LA; Trovik J; Salvesen HB
Mod Pathol; 2013 Mar; 26(3):428-34. PubMed ID: 23080032
[TBL] [Abstract][Full Text] [Related]
16. Synchronous clear cell adenocarcinoma of the cervix and endometrioid carcinoma of the endometrium.
Park ST; Song MJ; Lee CW; Lee AW; Hur SY; Park JS
Eur J Gynaecol Oncol; 2011; 32(5):573-5. PubMed ID: 22053679
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of URI/RMP gene in endometrioid adenocarcinoma by tissue microarray immunohistochemistry.
Gu J; Liang Y; Qiao L; Li X; Li X; Lu Y; Zheng Q
Int J Clin Exp Pathol; 2013; 6(11):2396-403. PubMed ID: 24228101
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic analysis with immunohistochemistry for DNA mismatch repair protein expression in synchronous primary endometrial and ovarian cancers.
Kobayashi Y; Nakamura K; Nomura H; Banno K; Irie H; Adachi M; Iida M; Umene K; Nogami Y; Masuda K; Kisu I; Ueki A; Yamagami W; Kataoka F; Hirasawa A; Tominaga E; Susumu N; Aoki D
Int J Gynecol Cancer; 2015 Mar; 25(3):440-6. PubMed ID: 25695547
[TBL] [Abstract][Full Text] [Related]
19. Endometrioid adenocarcinoma with simultaneous endocervical and intestinal-type mucinous differentiation: report of a rare phenomenon and the immunohistochemical profile.
Buell-Gutbrod R; Sung CJ; Lawrence WD; Quddus MR
Diagn Pathol; 2013 Aug; 8():128. PubMed ID: 23915109
[TBL] [Abstract][Full Text] [Related]
20. Endometrial stromal sarcoma with endometrioid adenocarcinoma of the uterus: a case report.
Liu G; Zhang C; Ma Z; Zhang Q; Liu B
Int J Clin Exp Pathol; 2015; 8(5):5242-6. PubMed ID: 26191224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
